Caval valve implantation for tricuspid regurgitationStatus:Awaiting developmentProgramme:Interventional procedures guidanceExpected publication date: 21 August 2024
Acoramidis for treating transthyretin-mediated amyloidosis cardiomyopathy [ID6354]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy TSID 12015Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Vutrisiran for treating transthyretin-related amyloidosis with cardiomyopathy TSID 12037Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC